Treatment of Hepatitis C Post-Liver Transplantation Could Mitigate Discard Rates of Hepatitis C-Positive Deceased Donor Livers and Expand the Donor Pool

BACKGROUND: Prior to 2014, treatment for hepatitis C was limited. However, the subsequent introduction of direct acting antiviral medications (DAA) against hepatitis C led to improvements in morbidity and better medication tolerance. DAA therapy allowed for an increase in treatment rates of hepatiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Keller, Jennifer, Marklin, Gary, Okoye, Obi, Desai, Roshani, Sura, Tej, Jain, Ajay, Varma, Chintalapati, Nazzal, Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850848/
https://www.ncbi.nlm.nih.gov/pubmed/33564467
http://dx.doi.org/10.1155/2021/6612453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850848/
https://www.ncbi.nlm.nih.gov/pubmed/33564467
http://dx.doi.org/10.1155/2021/6612453

Ejemplares similares